戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and midurethral-sling surgery in women with stress urinary incontinence.
2 nst the benefits of preventing postoperative stress urinary incontinence.
3 atment of complications of sling surgery for stress urinary incontinence.
4 acious for the treatment of mild-to-moderate stress urinary incontinence.
5 nism by which NA reuptake inhibitors improve stress urinary incontinence.
6  the mainstay for treating postprostatectomy stress urinary incontinence.
7 operative intervention for all patients with stress urinary incontinence.
8 choice of operative procedure for women with stress urinary incontinence.
9  sling have a high success rate for treating stress urinary incontinence.
10 es when reporting on surgical management for stress urinary incontinence.
11 o be the front-line therapeutic modality for stress urinary incontinence.
12 ogous biological slings for the treatment of stress urinary incontinence.
13 may offer alternatives in difficult cases of stress urinary incontinence.
14 the treatment of choice in the management of stress urinary incontinence.
15 rofilometry) prior to surgical treatment for stress urinary incontinence.
16 in the preoperative evaluation of women with stress urinary incontinence.
17 e the best outcome of surgical treatment for stress urinary incontinence.
18 ontinence is largely limited to treatment of stress urinary incontinence.
19 ing agents may prove useful for all types of stress urinary incontinence.
20                                              Stress urinary incontinence after prostate cancer treatm
21 gher cure rate for patients with predominant stress urinary incontinence and can safely be placed at
22 ns the most efficacious treatment for severe stress urinary incontinence and for radiated patients.
23 and long-term complications from mesh use in stress urinary incontinence and pelvic organ prolapse re
24  been raised about the safety of surgery for stress urinary incontinence and pelvic organ prolapse us
25  recent advances for the treatment of female stress urinary incontinence and pelvic organ prolapse.
26 rend is to use synthetic grafts in repair of stress urinary incontinence and pelvic organ prolapse.
27 s seen with the use of vaginal mesh for both stress urinary incontinence and POP.
28        Two months after surgery, he had mild stress urinary incontinence and PSA of < 0.1 ng/mL.
29  suburethral slings used in the treatment of stress urinary incontinence and the management of these
30 bdominal sacrocolpopexy can reduce secondary stress urinary incontinence and urge urinary incontinenc
31 The two main types of incontinence in women, stress urinary incontinence and urge urinary incontinenc
32    Newer tissue bulking agents used to treat stress urinary incontinence and vesicoureteral reflux pr
33 Many operations have been developed to treat stress urinary incontinence and yet, at present, there i
34   New techniques for the treatment of female stress urinary incontinence are constantly being develop
35 nvasive and minimally-invasive therapies for stress urinary incontinence are expanding.
36                  Prevention of postoperative stress urinary incontinence at the time of prolapse repa
37 roach, it is less clear that the severity of stress urinary incontinence, based on either abdominal l
38 g evidence exists concerning its efficacy in stress urinary incontinence, but its benefit to women wi
39 Duloxetine exerts only modest relief of male stress urinary incontinence, but may be recommended in s
40 mmonly performed in women before surgery for stress urinary incontinence, but there is no good eviden
41  incontinence with weight loss, for treating stress urinary incontinence by performing anti-incontine
42 gest that patients with more severe forms of stress urinary incontinence by urodynamic testing fare m
43 med on the pharmacological treatment of male stress urinary incontinence, confirming that duloxetine
44 e vaginal tape is the foremost technique for stress urinary incontinence correction, many of the newe
45                                   Subjective stress urinary incontinence 'cure/improvement' rates aft
46 rodynamics in the preoperative assessment of stress urinary incontinence, especially at this time of
47 using the recommendations made by the Female Stress Urinary Incontinence Guidelines Panel summary rep
48 ent studies are getting closer to the female stress urinary incontinence guidelines.
49            The use of slings to treat female stress urinary incontinence has had resurgence with new
50 ess invasive techniques emerge, treatment of stress urinary incontinence has increased over time.
51                  As treatment strategies for stress urinary incontinence have developed over the last
52 t assess outcomes in the treatment of female stress urinary incontinence illustrate many of the curre
53 ents are frequently used in the treatment of stress urinary incontinence in a variety of patients.
54 s to consider when choosing an operation for stress urinary incontinence in an individual patient.
55  been used successfully for the treatment of stress urinary incontinence in both male and female pati
56 te of adverse events of these procedures for stress urinary incontinence in England over 8 years.
57 ical procedure for contemporary treatment of stress urinary incontinence in individual patients.
58 ly, there are excellent options for managing stress urinary incontinence in men, and recent data have
59  Recent studies demonstrate that surgery for stress urinary incontinence in older women improves symp
60 d the approach to the surgical management of stress urinary incontinence in women and marked a resurg
61 the evidence base for surgical management of stress urinary incontinence in women between July 2006 a
62 elvic-organ prolapse decreases postoperative stress urinary incontinence in women without preoperativ
63 ications on the evaluation and management of stress urinary incontinence in women.
64 g surgical intervention for the treatment of stress urinary incontinence in women.
65                               For women with stress urinary incontinence, initial midurethral-sling s
66           Further research into the cause of stress urinary incontinence is necessary.
67                                Patients with stress urinary incontinence mainly suffer from malfuncti
68 ggest that a familial predisposition towards stress urinary incontinence may exist.
69 ing is advocated as first-line treatment for stress urinary incontinence; midurethral-sling surgery i
70 years after vaginal surgery for prolapse and stress urinary incontinence, neither ULS nor SSLF was si
71 5), rectocele (OR, 4.9; 95% CI, 1.3-19), and stress urinary incontinence (OR, 3.1; 95% CI, 1.4-6.5),
72                                              Stress urinary incontinence, overflow incontinence and d
73 cter regeneration has shown promise in adult stress urinary incontinence patients, but its applicabil
74   For women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluat
75  the 'success rates' published for different stress urinary incontinence procedures.
76 incontinence due to overactive bladder or to stress urinary incontinence published in peer-reviewed j
77           Proper diagnosis and evaluation of stress urinary incontinence remains paramount in prevent
78 ocedures, we give insight into the future of stress urinary incontinence research and outcomes.
79    Objective parameters in the evaluation of stress urinary incontinence, such as questionnaires, pad
80 harmacology in a preclinical canine model of stress urinary incontinence (SUI) and no measurable func
81 f synthetic slings for the treatment of male stress urinary incontinence (SUI) has increased over the
82 ed in pelvic organ prolapse (POP) repair and stress urinary incontinence (SUI) to augment and strengt
83                                              Stress urinary incontinence (SUI) with more than 1 sympt
84 FDs), including pelvic organ prolapse (POP), stress urinary incontinence (SUI), urge urinary incontin
85 he current evidence for the genetic basis of stress urinary incontinence (SUI).
86 he most common surgical treatment for female stress urinary incontinence (SUI).
87 apse (POP) surgery in women who present with stress urinary incontinence (SUI).
88   Results from randomized trials focusing on stress urinary incontinence surgery in older women are n
89      To review recently published studies on stress urinary incontinence surgery outcomes in older wo
90 lving women with uncomplicated, demonstrable stress urinary incontinence to compare outcomes after pr
91 dynamic testing enhances surgical outcome of stress urinary incontinence treatments by improving case
92                                Women without stress urinary incontinence undergoing vaginal surgery f
93 ry to treat both apical vaginal prolapse and stress urinary incontinence was conducted between 2008 a
94 tant with 'hidden', 'potential', or 'occult' stress urinary incontinence when the prolapse is reduced
95 ibuted level 1 evidence in the management of stress urinary incontinence with multicentric randomized
96  of the role of preoperative urodynamics for stress urinary incontinence, with particular reference t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。